These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
196 related items for PubMed ID: 25483690
1. Mortality among recipients of the Merck V710 Staphylococcus aureus vaccine after postoperative S. aureus infections: an analysis of possible contributing host factors. McNeely TB, Shah NA, Fridman A, Joshi A, Hartzel JS, Keshari RS, Lupu F, DiNubile MJ. Hum Vaccin Immunother; 2014; 10(12):3513-6. PubMed ID: 25483690 [Abstract] [Full Text] [Related]
3. Phase IIa study of the immunogenicity and safety of the novel Staphylococcus aureus vaccine V710 in adults with end-stage renal disease receiving hemodialysis. Moustafa M, Aronoff GR, Chandran C, Hartzel JS, Smugar SS, Galphin CM, Mailloux LU, Brown E, Dinubile MJ, Kartsonis NA, Guris D. Clin Vaccine Immunol; 2012 Sep; 19(9):1509-16. PubMed ID: 22837094 [Abstract] [Full Text] [Related]
4. The immunogenicity and safety of different formulations of a novel Staphylococcus aureus vaccine (V710): results of two Phase I studies. Harro CD, Betts RF, Hartzel JS, Onorato MT, Lipka J, Smugar SS, Kartsonis NA. Vaccine; 2012 Feb 21; 30(9):1729-36. PubMed ID: 22192849 [Abstract] [Full Text] [Related]
5. Risk prediction for Staphylococcus aureus surgical site infection following cardiothoracic surgery; A secondary analysis of the V710-P003 trial. Paling FP, Olsen K, Ohneberg K, Wolkewitz M, Fowler VG, DiNubile MJ, Jafri HS, Sifakis F, Bonten MJM, Harbarth SJ, Kluytmans JAJW. PLoS One; 2018 Feb 21; 13(3):e0193445. PubMed ID: 29561866 [Abstract] [Full Text] [Related]
6. Safety and immunogenicity of a novel Staphylococcus aureus vaccine: results from the first study of the vaccine dose range in humans. Harro C, Betts R, Orenstein W, Kwak EJ, Greenberg HE, Onorato MT, Hartzel J, Lipka J, DiNubile MJ, Kartsonis N. Clin Vaccine Immunol; 2010 Dec 21; 17(12):1868-74. PubMed ID: 20943877 [Abstract] [Full Text] [Related]
7. Active Immunization with Extracellular Vesicles Derived from Staphylococcus aureus Effectively Protects against Staphylococcal Lung Infections, Mainly via Th1 Cell-Mediated Immunity. Choi SJ, Kim MH, Jeon J, Kim OY, Choi Y, Seo J, Hong SW, Lee WH, Jeon SG, Gho YS, Jee YK, Kim YK. PLoS One; 2015 Dec 21; 10(9):e0136021. PubMed ID: 26333035 [Abstract] [Full Text] [Related]
8. Is there a future for a Staphylococcus aureus vaccine? Proctor RA. Vaccine; 2012 Apr 19; 30(19):2921-7. PubMed ID: 22115633 [Abstract] [Full Text] [Related]
9. Two Vaccines for Staphylococcus aureus Induce a B-Cell-Mediated Immune Response. Dupont CD, Scully IL, Zimnisky RM, Monian B, Rossitto CP, O'Connell EB, Jansen KU, Anderson AS, Love JC. mSphere; 2018 Aug 22; 3(4):. PubMed ID: 30135219 [Abstract] [Full Text] [Related]
10. Immunity induced by Staphylococcus aureus surface protein A was protective against lethal challenge of Staphylococcus aureus in BALB/c mice. Yi SQ, Zhang XY, Yang YL, Yang Y, Liu SL, Fu L, Yu CM, Chen W. Microbiol Immunol; 2012 Jun 22; 56(6):406-10. PubMed ID: 22420921 [Abstract] [Full Text] [Related]
11. Improved protective efficacy of a chimeric Staphylococcus aureus vaccine candidate iron-regulated surface determinant B ( N 126- P 361) -target of RNAIII activating protein in mice. Yu L, Wang N, Ma J, Tong C, Song B, Chi J, Ma G, Zhu Z, Cui Y. Microbiol Immunol; 2013 Dec 22; 57(12):857-64. PubMed ID: 24117875 [Abstract] [Full Text] [Related]
12. Staphylococcus aureus antigens and challenges in vaccine development. Middleton JR. Expert Rev Vaccines; 2008 Aug 22; 7(6):805-15. PubMed ID: 18665778 [Abstract] [Full Text] [Related]
14. Immune response and functional role of antibodies raised in heifers against a Staphylococcus aureus CP5 lysate and recombinant antigens vaccine formulated with Iscom Matrix adjuvant. Camussone CM, Pujato N, Renna MS, Veaute CM, Morein B, Marcipar IS, Calvinho LF. Vet Immunol Immunopathol; 2014 Dec 15; 162(3-4):96-107. PubMed ID: 25454469 [Abstract] [Full Text] [Related]
15. Development of a vaccine against Staphylococcus aureus. Spellberg B, Daum R. Semin Immunopathol; 2012 Mar 15; 34(2):335-48. PubMed ID: 22080194 [Abstract] [Full Text] [Related]
16. Vaccination and passive immunisation against Staphylococcus aureus. Schaffer AC, Lee JC. Int J Antimicrob Agents; 2008 Nov 15; 32 Suppl 1():S71-8. PubMed ID: 18757184 [Abstract] [Full Text] [Related]
17. Immunotherapeutic approaches against Staphylococcus aureus. Verkaik NJ, van Wamel WJ, van Belkum A. Immunotherapy; 2011 Sep 15; 3(9):1063-73. PubMed ID: 21913829 [Abstract] [Full Text] [Related]
18. Use of a Staphylococcus aureus conjugate vaccine in patients receiving hemodialysis. Shinefield H, Black S, Fattom A, Horwith G, Rasgon S, Ordonez J, Yeoh H, Law D, Robbins JB, Schneerson R, Muenz L, Fuller S, Johnson J, Fireman B, Alcorn H, Naso R. N Engl J Med; 2002 Feb 14; 346(7):491-6. PubMed ID: 11844850 [Abstract] [Full Text] [Related]
19. Staphylococcal vaccine development: review of past failures and plea for a future evaluation of vaccine efficacy not only on staphylococcal infections but also on mucosal carriage. Botelho-Nevers E, Verhoeven P, Paul S, Grattard F, Pozzetto B, Berthelot P, Lucht F. Expert Rev Vaccines; 2013 Nov 14; 12(11):1249-59. PubMed ID: 24111513 [Abstract] [Full Text] [Related]
20. Vaccine review: "Staphyloccocus aureus vaccines: problems and prospects". Jansen KU, Girgenti DQ, Scully IL, Anderson AS. Vaccine; 2013 Jun 07; 31(25):2723-30. PubMed ID: 23624095 [Abstract] [Full Text] [Related] Page: [Next] [New Search]